Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor
- 17 May 2019
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (6) , 598-606
Abstract
Activation of hepatocyte growth factor (HGF) by proteolytic processing is triggered in cancer microenvironments, and subsequent signaling through the MET receptor is involved in cancer progression. However, the structure of HGF remains elusive, and few small/medium-sized molecules can modulate HGF. Here, we identified HiP-8, a macrocyclic peptide consisting of 12 amino acids, which selectively recognizes active HGF. Biochemical analysis and real-time single-molecule imaging by high-speed atomic force microscopy demonstrated that HiP-8 restricted the dynamic domains of HGF into static closed conformations, resulting in allosteric inhibition. Positron emission tomography using HiP-8 as a radiotracer enabled noninvasive visualization and simultaneous inhibition of HGF–MET activation status in tumors in a mouse model. Our results illustrate the conformational change in proteolytic activation of HGF and its detection and inhibition by a macrocyclic peptide, which may be useful for diagnosis and treatment of cancers.Keywords
This publication has 55 references indexed in Scilit:
- Cell-Autonomous and Non–Cell-Autonomous Mechanisms of HGF/MET–Driven Resistance to Targeted Therapies: From Basic Research to a Clinical PerspectiveCancer Discovery, 2013
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Targeting the HGF/Met signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- In Vitro Selection of Highly Modified Cyclic Peptides That Act as Tight Binding InhibitorsJournal of the American Chemical Society, 2012
- Production of Lantipeptides in Escherichia coliJournal of the American Chemical Society, 2010
- MET signalling: principles and functions in development, organ regeneration and cancerNature Reviews Molecular Cell Biology, 2010
- Noncompetitive Inhibition of Hepatocyte Growth Factor-dependent Met Signaling by a Phage-derived PeptideJournal of Molecular Biology, 2009
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience, 2007
- Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonistProceedings of the National Academy of Sciences, 2007